Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
{{output}}
Background: Controlled and real-world evidence have demonstrated the efficacy of calcitonin gene related peptide (CGRP) monoclonal antibodies (MABs) in migraine. However, data on the over-one-year sustained effectiveness of CGRP ... ...
